Kim Kardashian is no stranger to endorsing products of questionable quality (remember those Kardashian kredit kards she and her sisters pushed a few years ago?) but this time, the FDA is getting involved. The reality TV star posted an image to Instagram promoting DICLEGIS, a drug that is supposed to help with morning sickness.
The drug may have worked for Kim (if she ever really used it) but the FDA took issue with the fact that the expectant mother failed to list any risks or side-effects in her online shoutout. “The social media post is false or misleading in that it presents efficacy claims for DICLEGIS, but fails to communicate any risk information,” the FDA wrote in a letter to the DICLEGIS company. The drug is one that the FDA does not recommend for women with certain sensitivities – it also can affect mental alertness and hasn’t been studied in women with extreme morning sickness, big risk factors that should have been mentioned in the post, which was removed soon after.
We get it: no one wants to read an Instagram post with a mile-long list of possible side-effects to a drug that’s supposed to help them. But it is quite irresponsible to peddle something to pregnant women without mentioning the risks. Sure, Kim’s just trying to make an extra dollar, but with great endorsement power comes great responsibility.
[via Washington Post]